Postoperative adjuvant hepatic arterial infusion chemotherapy (HAIC) with FOLFOX to improve outcomes of patients with hepatocellular carcinoma with microvascular invasion: A prospective multicenter, phase 3, randomized, controlled clinical trial.
Shaohua Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Rongping Guo(Sun Yat-sen University), Chong Zhong(Guangzhou University of Chinese Medicine), Rui Luo(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Chongkai Fang(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Lie Zheng(Sun Yat-sen University), Jingduo Deng(Zhujiang Hospital), Mingrong Cao(First Affiliated Hospital of Jinan University), Yuchuan Jiang(First Affiliated Hospital of Jinan University), Huakun Huang(Zhujiang Hospital), Wei Wei(Zhujiang Hospital), Qiang Li(Central South University), Rongce Zhao(Sun Yat-sen University), Yuan Cheng(Zhujiang Hospital), Lianghe Lu(Sun Yat-sen University), Jie Mei(Sun Yat-sen University), Qiucheng Lei(Foshan Hospital of TCM), Jingwen Zou(Sun Yat-sen University), Huanwei Chen(Changhua Christian Hospital), Qiaoxuan Wang(Institute of Polymers)
Cited by 4
Related Papers
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
|Journal of Clinical Oncology|2020|217
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma
|Therapeutic Advances in Medical Oncology|2021|216
A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome
|European Journal of Endocrinology|2011|160